Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TDOC files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Departure of CFO (new) — The filing discloses the resignation of the Chief Legal Officer, not the CFO; the red flag trigger appears to be a mislabel.
NYSE: TDOC Teladoc Health, Inc. 8-K

Teladoc Health Chief Legal Officer Adam Vandervoort resigns effective Nov 1; Jonathan Dorfman named successor

Filed September 25, 2026 · Period ending September 24, 2026 · ~1 min read

3 key changes 1 red flag

Key Changes

  • medium

    Chief Legal Officer and Secretary Adam C. Vandervoort informed the company on September 24, 2026 of his decision to resign, effective November 1, 2026.

    Item 5.02 verify on EDGAR →
  • medium

    Jonathan Dorfman, currently Senior Vice President, Securities & Corporate Law, will assume the role of Chief Legal Officer and Secretary following Vandervoort's departure.

    Item 5.02 verify on EDGAR →
  • low

    Vandervoort will provide advisory services to support the transition until November 1, 2027, without compensation.

    Item 5.02 verify on EDGAR →

Summary

Teladoc Health disclosed that its Chief Legal Officer and Secretary, Adam C. Vandervoort, has resigned effective November 1, 2026. The company has already named a successor: Jonathan Dorfman, currently Senior Vice President of Securities & Corporate Law, will take over the role. Vandervoort will remain available in an advisory capacity until November 1, 2027, without compensation, to support the transition.

For retail investors, this is a routine executive transition with a clear succession plan already in place. The company has not indicated any disagreement or underlying issues related to the departure. The appointment of an internal successor suggests continuity in legal leadership. There are no material concerns raised by this filing. The transition appears orderly, and the company has provided a long advisory period to ensure a smooth handover.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 28, 2026 · How we verify